These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 22704854)

  • 1. Analgesic tolerance without demonstrable opioid-induced hyperalgesia: a double-blinded, randomized, placebo-controlled trial of sustained-release morphine for treatment of chronic nonradicular low-back pain.
    Chu LF; D'Arcy N; Brady C; Zamora AK; Young CA; Kim JE; Clemenson AM; Angst MS; Clark DJ
    Pain; 2012 Aug; 153(8):1583-1592. PubMed ID: 22704854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution of Analgesic Tolerance and Opioid-Induced Hyperalgesia Over 6 Months: Double-Blind Randomized Trial Incorporating Experimental Pain Models.
    Rowbotham MC; Wallace M
    J Pain; 2020; 21(9-10):1031-1046. PubMed ID: 32006699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioid tolerance and hyperalgesia in chronic pain patients after one month of oral morphine therapy: a preliminary prospective study.
    Chu LF; Clark DJ; Angst MS
    J Pain; 2006 Jan; 7(1):43-8. PubMed ID: 16414554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tolerance and opioid-induced hyperalgesia. Is a divorce imminent?
    Richebe P; Cahana A; Rivat C
    Pain; 2012 Aug; 153(8):1547-1548. PubMed ID: 22608577
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy and safety of OPANA ER (oxymorphone extended release) for relief of moderate to severe chronic low back pain in opioid-experienced patients: a 12-week, randomized, double-blind, placebo-controlled study.
    Hale ME; Ahdieh H; Ma T; Rauck R;
    J Pain; 2007 Feb; 8(2):175-84. PubMed ID: 17145204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous opioid inhibition of chronic low-back pain influences degree of back pain relief after morphine administration.
    Bruehl S; Burns JW; Gupta R; Buvanendran A; Chont M; Schuster E; France CR
    Reg Anesth Pain Med; 2014; 39(2):120-5. PubMed ID: 24553304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ACTION study: a randomized, open-label, multicenter trial comparing once-a-day extended-release morphine sulfate capsules (AVINZA) to twice-a-day controlled-release oxycodone hydrochloride tablets (OxyContin) for the treatment of chronic, moderate to severe low back pain.
    Rauck RL; Bookbinder SA; Bunker TR; Alftine CD; Ghalie R; Negro-Vilar A; de Jong E; Gershon S
    J Opioid Manag; 2006; 2(3):155-66. PubMed ID: 17319449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in morphine analgesia and side effects during daily subcutaneous administration in healthy volunteers.
    Petersen KL; Meadoff T; Press S; Peters MM; LeComte MD; Rowbotham MC
    Pain; 2008 Jul; 137(2):395-404. PubMed ID: 17977662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Contribution of Differential Opioid Responsiveness to Identification of Opioid Risk in Chronic Pain Patients.
    Bruehl S; Burns JW; Passik SD; Gupta R; Buvanendran A; Chont M; Schuster E; Orlowska D; France CR
    J Pain; 2015 Jul; 16(7):666-75. PubMed ID: 25892658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-entity hydrocodone extended-release capsules in opioid-tolerant subjects with moderate-to-severe chronic low back pain: a randomized double-blind, placebo-controlled study.
    Rauck RL; Nalamachu S; Wild JE; Walker GS; Robinson CY; Davis CS; Farr SJ
    Pain Med; 2014 Jun; 15(6):975-85. PubMed ID: 24517082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, open-label study of once-a-day AVINZA (morphine sulfate extended-release capsules) versus twice-a-day OxyContin (oxycodone hydrochloride controlled-release tablets) for chronic low back pain: the extension phase of the ACTION trial.
    Rauck RL; Bookbinder SA; Bunker TR; Alftine CD; Ghalie R; Negro-Vilar A; de Jong E; Gershon S
    J Opioid Manag; 2006; 2(6):325-8, 331-3. PubMed ID: 17326594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of remifentanil-induced analgesia, hyperalgesia, and tolerance by small-dose ketamine in humans.
    Luginbühl M; Gerber A; Schnider TW; Petersen-Felix S; Arendt-Nielsen L; Curatolo M
    Anesth Analg; 2003 Mar; 96(3):726-732. PubMed ID: 12598253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolerability, Safety, and Effectiveness of Oxycodone DETERx in Elderly Patients ≥65 Years of Age with Chronic Low Back Pain: A Randomized Controlled Trial.
    Kopecky EA; Vaughn B; Lagasse S; O'Connor M
    Drugs Aging; 2017 Aug; 34(8):603-613. PubMed ID: 28600725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association between negative affect and opioid analgesia in patients with discogenic low back pain.
    Wasan AD; Davar G; Jamison R
    Pain; 2005 Oct; 117(3):450-461. PubMed ID: 16154274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-reported cumulative medical opioid exposure and subjective responses on first use of opioids predict analgesic and subjective responses to placebo-controlled opioid administration.
    Bruehl S; Stone AL; Palmer C; Edwards DA; Buvanendran A; Gupta R; Chont M; Kennedy M; Burns JW
    Reg Anesth Pain Med; 2019 Jan; 44(1):92-99. PubMed ID: 30640659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous Opioid Function and Responses to Morphine: The Moderating Effects of Anger Expressiveness.
    Burns JW; Bruehl S; France CR; Schuster E; Orlowska D; Chont M; Gupta RK; Buvanendran A
    J Pain; 2017 Aug; 18(8):923-932. PubMed ID: 28365372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of oxymorphone extended release in chronic low back pain: results of a randomized, double-blind, placebo- and active-controlled phase III study.
    Hale ME; Dvergsten C; Gimbel J
    J Pain; 2005 Jan; 6(1):21-8. PubMed ID: 15629415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous opioid function mediates the association between laboratory-evoked pain sensitivity and morphine analgesic responses.
    Bruehl S; Burns JW; Gupta R; Buvanendran A; Chont M; Kinner E; Schuster E; Passik S; France CR
    Pain; 2013 Sep; 154(9):1856-1864. PubMed ID: 23748117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperalgesia induced by low-dose opioid treatment before orthopaedic surgery: An observational case-control study.
    Hina N; Fletcher D; Poindessous-Jazat F; Martinez V
    Eur J Anaesthesiol; 2015 Apr; 32(4):255-61. PubMed ID: 25485877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxymorphone extended release for the treatment of chronic low back pain: a retrospective pooled analysis of enriched-enrollment clinical trial data stratified according to age, sex, and prior opioid use.
    Peniston JH; Gould E
    Clin Ther; 2009 Feb; 31(2):347-59. PubMed ID: 19302907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.